Tritonix.ai

News / Taiwan / economic_daily

Ruentex-backed Dingjin Biotech Targets 2028 Launch for New Botox Product

Health Technology · Biotechnology · economic_daily · 2026-09-08

7876

Dingjin Biotech, backed by Ruentex Group, has completed Phase III clinical monitoring for its new botulinum toxin, aiming for a 2028 market entry in Taiwan.

What Happened

Clinical Milestones: Dingjin Biotech announced that its novel botulinum toxin, OBI-858, has completed Phase III clinical monitoring in Taiwan, with data unblinding expected in November and a drug license application slated for Q1 next year.

Market Strategy: The company aims to launch the product in Taiwan by the first half of 2028 to capture a share of the multibillion-dollar medical aesthetics market, with an IPO targeted for late 2027.

Safety Profile: Phase II trial results confirmed that OBI-858 maintains high safety and tolerability over one year of repeated use, with most patients requiring minimal treatments to sustain efficacy.

Corporate Backing: Ruentex Group holds approximately 60% of Dingjin Biotech, including a 49% stake held by OBI Pharma, and the company is currently raising over NT$400 million to fund ongoing development.

Read original

More in Health Technology

Joyo Pharm Reports 50% Revenue Surge in August

Health Technology · economic_daily · 2026-09-08

Joyo Pharmaceutical announced a 50% year-over-year revenue increase for August, driven by strong sales in oncology, cardiovascular, and women's health products.

4114

Sandoz CEO Warns Trump's Generic Drug Tariffs Will Burden U.S. Patients

Health Technology · cnbc · 2026-09-08

Sandoz CEO Richard Saynor warns that proposed U.S. tariffs on generic medicines could force manufacturers to hike prices or halt supply, impacting millions of patients.

SDZ-CH, NVO, NVO, NVS

Xufu August Revenue Soars 187.52% Year-over-Year

Health Technology · cnyes · 2026-09-08

Xufu (4119) reported August 2026 revenue of NT$149 million, a 187.52% year-over-year surge, with year-to-date revenue growth at 14.21%.

4119

Latest in Taiwan

AI Demand Drives Record-Breaking August Revenue for Unimicron and Gold Circuit Electronics

Electronic Technology · economic_daily · 2026-09-08

PCB giants Unimicron and Gold Circuit Electronics reported record-high August revenues, fueled by robust AI server demand and seasonal strength.

3037

MA-tek Reports Sixth Consecutive Month of Record Revenue Growth

Electronic Technology · economic_daily · 2026-09-08

Semiconductor testing firm MA-tek achieved record-breaking revenue for the sixth straight month in August, driven by robust demand for AI chip analysis from North American clients.

3587

Goldman Sachs Bullish on Optical Transceiver Industry Amid AI Boom

Electronic Technology · economic_daily · 2026-09-08

Goldman Sachs has upgraded its outlook for the optical transceiver sector, citing strong AI infrastructure demand and the transition to higher-speed connectivity.

3363

Taiwan Stocks Supported by Solid Fundamentals; Analysts Suggest Buying Dips

Electronic Technology · economic_daily · 2026-09-08

Despite mixed global manufacturing data, Taiwan's market remains resilient due to strong corporate earnings, with analysts favoring AI and consumer electronics sectors.